Michael Anthony Chen

Michael Chen practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Michael Chen's NPI, 1811073612, was assigned on October 27, 2006. Michael Chen graduated from University Of Michigan Medical School in 1999. Michael Chen's Washington license number on file is MD00041451.

Michael Chen's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Michael Chen's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Michael Chen is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Michael Chen to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Chen practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Michael Chen's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Michael Chen is board certified in cardiovascular disease by the American Board of Internal Medicine. Michael Chen has a license on file in Washington.

Dmand AI lists aneurysm, atrial fibrillation and flutter, chronic hypertension, circulation problems, congestive heart failure, coronary artery disease, heart blockage and heart failure among the conditions Michael Chen treats.

CMS data shows 1,242 Medicare services from Michael Chen across 16 procedure codes in 2024, for 736 Medicare patients. Medicare paid $47,982 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 736 Medicare patients who saw Michael Chen in 2024. The largest group is 65 to 74, with 275 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Chen's median patient age at 61, with 42% women.

In 2024, Michael Chen wrote 1,589 Medicare Part D claims for 178 patients. 80% of them were for generic drugs. CMS names the drug for 1,470 of them, across 25 drugs with 11 or more claims each, at $320,876 in total drug cost. In 2023, CMS named 1,351 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Michael Chen for performance year 2024, reported through an alternative payment model (APM). Michael Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Michael Chen, published from 2009 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Heart Diseases, Cardiac Tamponade and Cardiopulmonary Resuscitation. Michael Chen has published most often in Echocardiography. Michael Chen's most frequent co-authors are Edward Allen Gill, MD, Camilla T. Allen, MD and Jenelle Holst Badulak, MD.

CMS Open Payments shows 9 general payments to Michael Chen from 7 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 90% of the total. DePuy Synthes Sales Inc. paid the most, $89.

Dmand AI lists 1 award for Michael Chen.

Michael Chen graduated from University Of Michigan Medical School in 1999. Michael Chen is a member of ACC.

Michael Chen is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.